CMC

47.1

+0.36%↑

FUL

58.1

+1.75%↑

USAU

9.41

+3.98%↑

CMC

47.1

+0.36%↑

FUL

58.1

+1.75%↑

USAU

9.41

+3.98%↑

CMC

47.1

+0.36%↑

FUL

58.1

+1.75%↑

USAU

9.41

+3.98%↑

CMC

47.1

+0.36%↑

FUL

58.1

+1.75%↑

USAU

9.41

+3.98%↑

CMC

47.1

+0.36%↑

FUL

58.1

+1.75%↑

USAU

9.41

+3.98%↑

Search

Ashland Global Holdings Inc

Cerrado

SectorMateriales básicos

57.92 0.31

Resumen

Variación precio

24h

Actual

Mínimo

56.48

Máximo

57.93

Métricas clave

By Trading Economics

Ingresos

-181M

-165M

Ventas

-117M

405M

BPA

0.28

Rentabilidad por dividendo

2.73

Margen de beneficios

-40.741

Empleados

3,200

EBITDA

-223M

-140M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+34.75% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

2.73%

2.80%

Próximas Ganancias

29 abr 2025

Fecha Próximo Dividendo

13 jun 2025

Próxima Fecha de Ex Dividendo

30 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

2.8B

Apertura anterior

57.61

Cierre anterior

57.92

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

89 / 170 Clasificación en Basic materials

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Ashland Global Holdings Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

17 mar 2025, 11:00 UTC

Adquisiciones, fusiones, absorciones

Ashland Completes Sale of Avoca Business to Mane

28 ene 2025, 22:05 UTC

Ganancias

Ashland 1Q Adj EPS 28c >ASH

28 ene 2025, 22:04 UTC

Ganancias

Ashland Backs FY25 Sales $1.9B-$2.05B >ASH

28 ene 2025, 22:04 UTC

Ganancias

Ashland 1Q Sales $405M >ASH

28 ene 2025, 22:04 UTC

Ganancias

Ashland 1Q Cont Ops Loss/Shr $3.51 >ASH

28 ene 2025, 22:03 UTC

Ganancias

Ashland 1Q Loss/Shr $3.50 >ASH

6 nov 2024, 22:07 UTC

Ganancias

Ashland 4Q EPS 39c >ASH

6 nov 2024, 22:07 UTC

Ganancias

Ashland 4Q Sales $522M >ASH

6 nov 2024, 22:07 UTC

Ganancias

Ashland Sees FY25 Sales $1.90B-$2.05B >ASH

3 sept 2024, 11:00 UTC

Adquisiciones, fusiones, absorciones

Ashland Completes Sale of Nutraceuticals Business to Affil of Turnspire Capital Partners >ASH

6 ago 2024, 21:04 UTC

Ganancias

Ashland Sees FY Sales $2.1B >ASH

6 ago 2024, 21:03 UTC

Ganancias

Ashland Sees 4Q Sales $530M-$540M >ASH

6 ago 2024, 21:03 UTC

Ganancias

Ashland 3Q Adj EPS $1.49 >ASH

6 ago 2024, 21:02 UTC

Ganancias

Ashland 3Q Sales $544M >ASH

6 ago 2024, 21:02 UTC

Ganancias

Ashland 3Q Cont Ops EPS 60c >ASH

6 ago 2024, 21:02 UTC

Ganancias

Ashland 3Q EPS 12c >ASH

6 ago 2024, 21:02 UTC

Ganancias

Ashland Issues Outlook for 4Q and Full-Yr Fiscal 2024

7 may 2024, 11:01 UTC

Adquisiciones, fusiones, absorciones

Ashland: Transaction Is Expected to Close in 3Q >ASH

7 may 2024, 10:59 UTC

Adquisiciones, fusiones, absorciones

Ashland Signs Definitive Agreement to Sell Nutraceuticals Business to Turnspire Capital Partners >ASH

Comparación entre iguales

Cambio de precio

Ashland Global Holdings Inc previsión

Precio Objetivo

By TipRanks

34.75% repunte

Estimación a 12 Meses

Media 77.86 USD  34.75%

Máximo 93 USD

Mínimo 68 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Ashland Global Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

8 ratings

5

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

56.33 / 59.72Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Weak Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

89 / 170 Clasificación en Materiales básicos

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Ashland Global Holdings Inc

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.